Valuation: Berkley Renewables Inc.

Market Cap 364K 330K 304K 275K 519K 34.27M 535K 3.65M 1.45M 18.25M 1.37M 1.34M 58.25M P/E 2016
4.22x
P/E 2017 -1.16x
Enterprise Value 5.13M 4.64M 4.28M 3.87M 7.31M 482M 7.53M 51.36M 20.41M 257M 19.24M 18.83M 819M EV / Sales 2016
3.53x
EV / Sales 2017 3.18x
Free-Float
90.7%
Yield 2016 *
-
Yield 2017 -
Manager TitleAgeSince
Chief Executive Officer 63 2002-06-19
Director of Finance/CFO - -
Director TitleAgeSince
Chairman 63 -
Director/Board Member 66 2006-08-16
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 459K
+1.60%+2.28%+54.44%+21.15% 163B
+0.50%+1.21%+54.34%+57.23% 99.59B
+1.20%+5.82%+42.33%+26.83% 79.73B
+1.47%+6.50%+1.18%+4.56% 70.8B
+2.03%+1.87%+39.55%-4.23% 57.23B
+0.78%+0.29%+28.61%+38.07% 55.59B
+1.73%+3.91%+61.10%+65.37% 51.41B
+1.33%-0.37%+22.98%+15.53% 50.52B
+2.85%+4.78%+31.48%+1.34% 51.23B
Average +1.35%+1.32%+37.33%+25.09% 68B
Weighted average by Cap. +1.43%+1.49%+40.51%+26.06%

Financials

2016 2017
Net sales 1.03M 936K 862K 781K 1.47M 97.23M 1.52M 10.36M 4.12M 51.78M 3.88M 3.8M 165M 1.72M 1.56M 1.44M 1.3M 2.46M 162M 2.53M 17.28M 6.87M 86.36M 6.47M 6.33M 276M
Net income 173K 156K 144K 130K 246K 16.24M 254K 1.73M 688K 8.65M 648K 634K 27.61M -631K -570K -526K -476K -899K -59.29M -927K -6.32M -2.51M -31.57M -2.37M -2.32M -101M
Net Debt 2.92M 2.64M 2.43M 2.2M 4.16M 274M 4.29M 29.23M 11.61M 146M 10.95M 10.71M 466M 4.76M 4.31M 3.97M 3.6M 6.79M 448M 7M 47.7M 18.96M 238M 17.87M 17.49M 761M
Logo Berkley Renewables Inc.
Berkley Renewables Inc. is a Canada-based, growth-oriented diversified issuer also pursuing renewable energy opportunities, primarily in the solar energy sector. The Company is pursuing solar energy investments in Ontario, Canada. It is also engaged in developing autologous cell therapies to treat conditions linked to a deficit of healthy cells required for normal healing and function through RepliCel Life Sciences Inc. The Company's RCT-01, RCS-01, and RCH-01 cell therapies are designed to treat chronic tendinosis, damaged or aged skin and pattern baldness. The Company is also developing a proprietary injection device (RCI) for optimal clinical delivery. The Company is developing solar photovoltaic (PV) projects in Ontario, Canada, through its subsidiary, Solar Flow-Through General Partnership. Working with Solar Flow-Through, the Company has also developed a flow-through investment vehicle for investors to participate in Ontario's solar energy growth.
Employees
-